Catalog11 refs
Ovagen
BioregulatorsReproductiveResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
DNA
Overview
Ovagen is a synthetic ultra-short peptide, marketed as the tripeptide Glu-Asp-Leu (EDL), and grouped with the Khavinson-style peptide bioregulators promoted for liver and gastrointestinal support. It is claimed to act at the gene-expression level in a tissue-specific manner, with proposed targets being hepatocytes (liver cells) and gastrointestinal epithelium. Evidence is sparse, with no registered human clinical trials and most claims tracing back to product marketing rather than controlled experiments.
Primary Uses
Ovarian support research
Female endocrine aging
Hormonal balance studies
Reproductive tissue support
Reduces long-term liver fibrosis
Protects GI mucosal layer from antibiotics, environmental toxins, and chemotherapy
Hepatoprotection through gene expression regulation
Antibiotic recovery and GI damage protection
Defense against environmental toxin effects on GI tract
Addresses age-related liver changes
Supports GI tract function during aging
Part of comprehensive anti-aging protocols
Ovarian tissue support
Ovarian research
Modulate gene expression in ovarian cells
Influence hormone production in ovaries
Liver support
Gastrointestinal support
Reduction of liver fibrosis (claimed)
Gut mucosa protection (claimed)
Protocol Reference
Dose
100 mcg Injection: 1–2 mg
Frequency
Daily
Half-life
Short (tripeptide)
Route
Oral · Injection
Evidence
Preclinical / Moderate Research (disputed)
Research References· 14
Research Models
HumanRatanimalbeef cowsdairy cattleewesgoats
Also in Bioregulators